The activated form of vitamin D-3, 1 alpha,25(OH)(2)D-3, not only plays a c
entral role in bone and calcium metabolism but has also potent antiprolifer
ative and prodifferentiating effects. Moreover, the combined presence of 25
(OH)D-3-1 alpha-hydroxylase as well as the vitamin D receptor in several ti
ssues introduced the idea of a paracrine role for 1 alpha,25(OH)(2)D-3. By
introducing chemical modifications into the flexible parent molecule 1 alph
a,25(OH)(2)D-3, a whole generation of vitamin D analogs was created, Due to
a clear dissociation of the antiproliferative and prodifferentiating effec
ts from calcemic effects, these analogs can be used not only for the treatm
ent of bone disorders but also for non-classical applications. Copyright (C
) 2000 S. Karger AG, Basel.